Robert G. Lerner, M.D.
In the past three years, Dr. Lerner has served as a consultant for RPR, and has served on the Speakers' Bureau for Pharmacia & Upjohn.
This activity is made possible by an unrestricted educational grant from the Novartis Foundation for Gerontology.
Estimated time to complete:
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Upon completion of this Cyberounds®
, you should be able to:
- Describe the term "thrombophilia" and list the recently discovered thrombophilic mutations such as Factor V Leiden, Prothrombin G20210A and MTHFR
- Discuss the increased risk of thrombosis for pregnant women with thrombophilia, and the risk of pregnancy loss and complications
- Discuss the preliminary data supportive of enoxaparin to prevent pregnancy loss.